IT8947794A0 - Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle - Google Patents

Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle

Info

Publication number
IT8947794A0
IT8947794A0 IT8947794A IT4779489A IT8947794A0 IT 8947794 A0 IT8947794 A0 IT 8947794A0 IT 8947794 A IT8947794 A IT 8947794A IT 4779489 A IT4779489 A IT 4779489A IT 8947794 A0 IT8947794 A0 IT 8947794A0
Authority
IT
Italy
Prior art keywords
formulations
preparing
contain
applying
biologically active
Prior art date
Application number
IT8947794A
Other languages
English (en)
Other versions
IT1232827B (it
Inventor
Jean-Michel Dayer
Philippe Lucien Seckinger
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IT8947794A0 publication Critical patent/IT8947794A0/it
Application granted granted Critical
Publication of IT1232827B publication Critical patent/IT1232827B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT8947794A 1988-03-31 1989-03-30 Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle IT1232827B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888807803A GB8807803D0 (en) 1988-03-31 1988-03-31 Biochemical product

Publications (2)

Publication Number Publication Date
IT8947794A0 true IT8947794A0 (it) 1989-03-30
IT1232827B IT1232827B (it) 1992-03-05

Family

ID=10634493

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8947794A IT1232827B (it) 1988-03-31 1989-03-30 Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle

Country Status (12)

Country Link
JP (1) JPH02117700A (it)
KR (1) KR890014125A (it)
AU (1) AU3228789A (it)
BE (1) BE1001845A4 (it)
DE (1) DE3910323A1 (it)
DK (1) DK156589A (it)
FR (1) FR2629345A1 (it)
GB (2) GB8807803D0 (it)
IL (1) IL89804A0 (it)
IT (1) IT1232827B (it)
NL (1) NL8900779A (it)
SE (1) SE8901115L (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83878A (en) * 1987-09-13 1995-07-31 Yeda Res & Dev Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
US5811261A (en) * 1988-09-12 1998-09-22 Yeda Research And Development Co. Ltd. Expression of the recombinant tumor necrosis factor binding protein I (TBP-I)
DK0393438T3 (da) * 1989-04-21 2005-05-30 Amgen Inc TNF-receptor, TNF-bindende proteiner og DNAér, der koder herfor
US7264944B1 (en) 1989-04-21 2007-09-04 Amgen Inc. TNF receptors, TNF binding proteins and DNAs coding for them
US6221675B1 (en) 1989-04-21 2001-04-24 Amgen, Inc. TNF receptors, TNF binding proteins and DNAs coding for them
IL95031A (en) 1989-07-18 2007-03-08 Amgen Inc Method for the production of a human recombinant tumor necrosis factor inhibitor
US6143866A (en) * 1989-07-18 2000-11-07 Amgen, Inc. Tumor necrosis factor (TNF) inhibitor and method for obtaining the same
US5605690A (en) * 1989-09-05 1997-02-25 Immunex Corporation Methods of lowering active TNF-α levels in mammals using tumor necrosis factor receptor
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
US5945397A (en) * 1989-09-05 1999-08-31 Immunex Corporation Purified p75 (type II) tumor necrosis factor receptor polypeptides
CA2485553A1 (en) * 1989-09-05 1991-03-21 Immunex Corporation Tumor necrosis factor - .alpha. and - .beta. receptors
DE59010908D1 (de) * 1989-09-12 2000-08-10 Hoffmann La Roche TNF-bindende Proteine
US6552170B1 (en) 1990-04-06 2003-04-22 Amgen Inc. PEGylation reagents and compounds formed therewith
WO1992001002A1 (en) * 1990-07-11 1992-01-23 Teijin Limited Tumor necrosis factor activity inhibitor and production thereof
EP0480389A1 (de) * 1990-10-12 1992-04-15 Hoechst Aktiengesellschaft Inhibitoren für die Bildung von Tumor Nekrose Faktor, Verfahren zu deren Herstellung und deren Verwendung
AU1235692A (en) * 1991-01-18 1992-08-27 Synergen, Inc. Methods for treating tumor necrosis factor mediated diseases
JPH06510122A (ja) * 1991-08-23 1994-11-10 エヌチップ　インコーポレイテッド パッケージされていない集積回路のバーン・イン技術
IT1276040B1 (it) * 1993-07-27 1997-10-24 Angelini Francesco Ist Ricerca Uso della benzidamina nel trattamento di stati patologici causati dal tnf
TW555765B (en) 1996-07-09 2003-10-01 Amgen Inc Low molecular weight soluble tumor necrosis factor type-I and type-II proteins
DK0942740T3 (da) 1996-12-06 2003-12-15 Amgen Inc Kombinationsterapi under anvendelse af et TFN-bindende protein til behandling af TFN-medierede sygdomme
CA2273852C (en) 1996-12-06 2009-09-29 Amgen Inc. Combination therapy using an il-1 inhibitor for treating il-1 mediated diseases
US6660843B1 (en) 1998-10-23 2003-12-09 Amgen Inc. Modified peptides as therapeutic agents
US6808902B1 (en) 1999-11-12 2004-10-26 Amgen Inc. Process for correction of a disulfide misfold in IL-1Ra Fc fusion molecules
CA2451955C (en) 2001-06-26 2015-09-29 Abgenix, Inc. Antibodies to opgl
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
WO2004060911A2 (en) 2002-12-30 2004-07-22 Amgen Inc. Combination therapy with co-stimulatory factors
US7833527B2 (en) 2006-10-02 2010-11-16 Amgen Inc. Methods of treating psoriasis using IL-17 Receptor A antibodies
TW201117824A (en) 2009-10-12 2011-06-01 Amgen Inc Use of IL-17 receptor a antigen binding proteins
SI3295957T1 (sl) 2010-01-15 2020-02-28 Kirin-Amgen, Inc. Formulacija protitelesa proti IL-17RA in terapevtski režim za zdravljenje luskavice
US20140234330A1 (en) 2011-07-22 2014-08-21 Amgen Inc. Il-17 receptor a is required for il-17c biology
JP6596014B2 (ja) 2014-03-31 2019-10-23 アムジェン ケー・エー，インコーポレイテッド 爪および頭皮乾癬の治療方法

Also Published As

Publication number Publication date
GB2218101A (en) 1989-11-08
KR890014125A (ko) 1989-10-21
FR2629345A1 (fr) 1989-10-06
SE8901115L (sv) 1989-10-01
DK156589D0 (da) 1989-03-30
NL8900779A (nl) 1989-10-16
GB8907148D0 (en) 1989-05-10
JPH02117700A (ja) 1990-05-02
DK156589A (da) 1989-10-01
GB8807803D0 (en) 1988-05-05
BE1001845A4 (fr) 1990-03-20
IL89804A0 (en) 1989-09-28
DE3910323A1 (de) 1989-10-19
IT1232827B (it) 1992-03-05
AU3228789A (en) 1989-10-05
SE8901115D0 (sv) 1989-03-30

Similar Documents

Publication Publication Date Title
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
FI891591A7 (fi) Ihonhoitokoostumus ja menetelmä sen valmistamiseksi
FI884051L (fi) Menetelmä stabiloitujen humaaniproteiinivalmisteiden valmistamiseksi
IT1208521B (it) Elettrodo, apparecchiatura e defibrillazione per l'impianto in corpi umani o animali.
IT1232149B (it) Composizione farmaceutica contenente ranitidina, e metodo per prepararla
FI862095A7 (fi) Käyttösysteemi aktiivisia aineosia varten ja menetelmä sen valmistamiseksi.
LTIP1654A (en) Protein, biologically active hormone, pharmaceutical preparation
FI864654L (fi) Menetelmä modifioidun ihmisen t-PA-proteiinin valmistamiseksi
FI892053L (fi) Laite aineiden luovuttamiseksi, menetelmä sen valmistamiseksi sekä sen käyttö
FI881061A7 (fi) Hitaasti vapauttavia valmisteita ruoansulatuskanavan ulkopuolisesti annettaviksi ja niiden käyttö.
FI882746A7 (fi) Hybridiproteiini C ja menetelmä sen valmistamiseksi.
DE68908114D1 (de) Implantierbares system fuer eine kuenstliche harnblase.
FI873905A7 (fi) Terapeuttinen koostumus ja menetelmä.
IL75828A (en) Immobilization by biologically active proteins
FI903613A7 (fi) Luovutussysteemi aktiiviaineita varten
IS3514A7 (is) Aðferð til að vinna líffræðilega virk efni
DK109590A (da) Biologisk aktivt protein
FI880636A7 (fi) Menetelmä vaipallisten virusten inaktivoimiseksi solun avulla in vitro valmistetuissa proteiinivalmisteissa.
EP0390849A4 (en) Methyl cellulose pharmaceutical composition
DE69009148D1 (de) Haarwuchs stimulierender agent.
FR2627778B1 (fr) Gene de structure, proteine endotoxine correspondante et application insecticide
FI892986L (fi) Kurkuliini-proteiini, menetelmä sen valmistamiseksi ja sen käyttö
NO910090L (no) Vevstransplantat-sammensetning og metode.
FI935725A7 (fi) Aktiivisia maitoproteiinikomponentteja sisältäviä komponentteja ja menetelmä niiden valmistamiseksi
IT8720800A0 (it) Composto attivo nella terapia carciovascolare.